Abstract
Background—: Microvascular obstruction seems to predict poor outcome in patients undergoing elective percutaneous coronary intervention (PCI), but the underlying mechanism is still unclear. We analyzed whether serum thromboxane B 2 , a stable metabolite of thromboxane A 2 , may be implicated in post-PCI microvascular obstruction. Methods and Results—: We enrolled 91 patients (74 males, 66±10 years) on chronic low-dose aspirin therapy (aspirin, 100 mg daily) scheduled for elective PCI and randomly assigned to receive aspirin reload (325 mg orally, n=46) or no reload (control group, n=45) ≥1 hour before elective PCI. Serum levels of thromboxane B 2 , reperfusion indexes (corrected Thrombolysis In Myocardial Infarction frame count and myocardial blush grade), and serum cardiac troponin I were assessed before and after PCI. Serum thromboxane B 2 significantly increased after 120 minutes ( P =0.0447) from PCI in control but not in aspirin reload group. After PCI, both groups showed a statistically significant reduction in corrected Thrombolysis In Myocardial Infarction frame count more evident in aspirin reload group ( P =0.0023). Moreover, after PCI, 61% of patients allocated to aspirin reload and only 32% of patients allocated to control group reached normal microcirculatory reperfusion (myocardial blush grade=3); patients with myocardial blush grade=3 exhibited lower values of serum thromboxane B 2 compared with those with myocardial blush grade P =0.05). Periprocedural cardiac troponin I significantly increased (F=3.64; P =0.01334) and correlated with serum thromboxane B 2 (ρ=0.31; P =0.0413) in control but not in aspirin reload group. In addition, left ventricular ejection fraction significantly increased after PCI only in the aspirin reload group ( P =0.0005). Conclusions—: Aspirin loading dose before elective PCI improves myocardial reperfusion and injury indexes, suggesting a possible role of platelet thromboxane A 2 in microvascular occlusion. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01374698.

This publication has 32 references indexed in Scilit: